XML 50 R35.htm IDEA: XBRL DOCUMENT v3.22.4
Revenues - Revenues Disaggregated by Significant Customer (Details) - Customer concentration risk
12 Months Ended
Dec. 30, 2022
Dec. 31, 2021
Jan. 01, 2021
Affiliates of AmerisourceBergen Corporation | Sales revenue, net      
Concentration Risk [Line Items]      
Percent of total revenues 18.00% 14.00% 11.00%
Affiliates of AmerisourceBergen Corporation | Accounts Receivable      
Concentration Risk [Line Items]      
Percent of total revenues 18.00% 11.00%  
Affiliates of McKesson Corporation | Sales revenue, net      
Concentration Risk [Line Items]      
Percent of total revenues 17.00% 14.00% 12.00%
Affiliates of McKesson Corporation | Accounts Receivable      
Concentration Risk [Line Items]      
Percent of total revenues 22.00% 10.00%  
Affiliates of CVS Health Corporation | Sales revenue, net      
Concentration Risk [Line Items]      
Percent of total revenues 17.00% 14.00% 14.00%
Affiliates of CVS Health Corporation | Accounts Receivable      
Concentration Risk [Line Items]      
Percent of total revenues 18.00% 9.00%  
Ipsen Pharma SAS | Sales revenue, net      
Concentration Risk [Line Items]      
Percent of total revenues 10.00% 21.00% 15.00%
Ipsen Pharma SAS | Accounts Receivable      
Concentration Risk [Line Items]      
Percent of total revenues 20.00% 50.00%  
Accredo Health, Incorporated | Sales revenue, net      
Concentration Risk [Line Items]      
Percent of total revenues 10.00% 9.00% 9.00%
Affiliates of Optum Specialty Pharmacy | Sales revenue, net      
Concentration Risk [Line Items]      
Percent of total revenues 10.00% 8.00% 11.00%
Cardinal Health, Inc. | Accounts Receivable      
Concentration Risk [Line Items]      
Percent of total revenues 11.00% 6.00%